Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-06T04:20:15.128Z Has data issue: false hasContentIssue false

Applicability of the adult comorbidity evaluation – 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospectivestudy

Published online by Cambridge University Press:  08 March 2006

V. Paleri
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, North Riding Infirmary, Middlesbrough, UK
R. G. Wight
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, North Riding Infirmary, Middlesbrough, UK

Abstract

The term comorbidity stands for disease processes that co-exist and are not related to the index disease being studied. Comorbidity in cancer has been shown to be a major determinant in treatment selection and survival. Patients with head and neck cancer can have significant comorbidity owing to the high incidence of tobacco and alcohol abuse. No studies to date have addressed this problem in head and neck cancer patients in the United Kingdom. The applicability of the adult comorbidity evaluation – 27 index (ACE-27) and the Charlson index (CI) to assess the comorbidity burden by retrospective notes review is studied here. Retrospective data collection and completion of a comorbidity index in a United Kingdom setting is feasible. We conclude that the pre-assessment visit is a useful time to record comorbidity and as a significant amount of information required for grading relates to historical items, this is best done using a self-administered patient questionnaire.

Type
Research Article
Copyright
© Royal Society of Medicine Press Limited 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)